Echinacea (angustifolia), Sabal Serrulata, Sarsaparilla (smilax Regelii), Solidago Virgaurea, Zincum Sulphuricum, Phytolacca Decandra, Hydrastis Canadensis, Orchitinum (suis), Prostate (suis), Clematis Erecta, Phosphoricum Acidum, Pulsatilla (vulgaris)
Generic Name: echinacea (angustifolia), sabal serrulata, sarsaparilla (smilax regelii), solidago virgaurea, zincum sulphuricum, phytolacca decandra, hydrastis canadensis, orchitinum (suis), prostate (suis), clematis erecta, phosphoricum acidum, pulsatilla (vulgaris)
Brand Names:
Prostatone
Dosage form: LIQUID. Route: ORAL. Active ingredients: CLEMATIS RECTA FLOWERING TOP (12 [hp_X]/mL); ECHINACEA ANGUSTIFOLIA WHOLE (3 [hp_X]/mL); GOLDENSEAL (5 [hp_X]/mL); PHOSPHORIC ACID (12 [hp_X]/mL); PHYTOLACCA AMERICANA ROOT (4 [hp_X]/mL); PULSATILLA VULGARIS WHOLE (12 [hp_X]/mL); SAW PALMETTO (3 [hp_X]/mL); SMILAX ORNATA ROOT (3 [hp_X]/mL); SOLIDAGO VIRGAUREA FLOWERING TOP (3 [hp_X]/mL); SUS SCROFA PROSTATE (8 [hp_X]/mL); SUS SCROFA TESTICLE (8 [hp_X]/mL); ZINC SULFATE HEPTAHYDRATE (3 [hp_X]/mL). Category: UNAPPROVED HOMEOPATHIC.
Overview
Dosage form: LIQUID. Route: ORAL. Active ingredients: CLEMATIS RECTA FLOWERING TOP (12 [hp_X]/mL); ECHINACEA ANGUSTIFOLIA WHOLE (3 [hp_X]/mL); GOLDENSEAL (5 [hp_X]/mL); PHOSPHORIC ACID (12 [hp_X]/mL); PHYTOLACCA AMERICANA ROOT (4 [hp_X]/mL); PULSATILLA VULGARIS WHOLE (12 [hp_X]/mL); SAW PALMETTO (3 [hp_X]/mL); SMILAX ORNATA ROOT (3 [hp_X]/mL); SOLIDAGO VIRGAUREA FLOWERING TOP (3 [hp_X]/mL); SUS SCROFA PROSTATE (8 [hp_X]/mL); SUS SCROFA TESTICLE (8 [hp_X]/mL); ZINC SULFATE HEPTAHYDRATE (3 [hp_X]/mL). Category: UNAPPROVED HOMEOPATHIC.
Dosage
Available as liquid for oral use.
Related Medications
Olea Europaea
olea europaea
Purpose Restore energy
Levonorgestrel
levonorgestrel
Progestin [EPC]
11 DESCRIPTION Skyla (levonorgestrel-releasing intrauterine system) contains 13.5 mg of LNG, a progestin, and is intended to provide an initial release rate of approximately14 mcg/day of LNG after 24 days.
Fludeoxyglucose F18
fludeoxyglucose f18
Radioactive Diagnostic Agent [EPC]
11 DESCRIPTION 11.1 Chemical Characteristics Fludeoxyglucose F 18 Injection is a positron emitting radiopharmaceutical that is used for diagnostic purposes in conjunction with positron emission tomography (PET) imaging.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.